title: Prospects for metabotropic glutamate 1 receptor antagonists in the treatment of neuropathic pain.
authors.affiliation: Lilly Research Labs, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, Indiana 46285, USA. jschkaryantz@Lilly.com
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Schkeryantz
authors.forename: Ann E
authors.initials: AE
authors.lastname: Kingston
authors.forename: Michael P
authors.initials: MP
authors.lastname: Johnson
mesh_terms: D000700:Analgesics / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D006801:Humans; D010146:Pain / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D018094:Receptors, Metabotropic Glutamate / Q000037:antagonists & inhibitors* / Q000502:physiology
chemical_list: D000700:Analgesics; D018094:Receptors, Metabotropic Glutamate; C104077:metabotropic glutamate receptor type 1